Editorial. Highlights the problems arising from the inability of licensed vaccine lots, such as the Haemophilus influenzae type b conjugate vaccine, in delivering expected immune response. Linking of bacterial polysaccharide to a protein carrier; Discovery of subimmunogenic vaccine lots; Change in immunogenicity in infants.